We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
BioVaxys Technology Corp., a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, announced the appointment of Adam Coutts, PhD, as Policy Advisor.